Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in-vitro fertilization cycle

Clinical and Experimental Obstetrics and Gynecology

Volumn 37, Issue 2, 2010, Pages 100-104

  Orvieto, R ^a,b   Shuhat, V ^a,b   Liberty, G ^a,b   Homburg, R ^a,b   Anteby, E Y ^a,b   Nahum, R ^a,b   Rabinson, J ^a,b   Meltcer, S ^a,b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

BMI; Insulin resistance; Ovulation induction; PCOS; Retinol binding protein 4; Sex steroids

Indexed keywords

CHORIONIC GONADOTROPIN; GLUCOSE; GONADORELIN ANTAGONIST; INSULIN; RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INSULIN BLOOD LEVEL; MENSTRUATION; OOCYTE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE; PROTEIN BLOOD LEVEL;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LONGITUDINAL STUDIES; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; RETINOL-BINDING PROTEINS, PLASMA; YOUNG ADULT;

EID: 77954016605     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril., 81, 19.
2. Stein I.F., Leventhal M.L.: "Amenorrhea associated with bilateral polycystic ovaries". Am. J. Obstet. Gynecol., 1935, 29, 181.
3. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A.: "Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia". J. Clin. Endocrinol Metab., 1987, 65, 499. (Pubitemid 17131438)
4. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyananthan R., Bush A. et al.: "The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries". Clin. Endocrinol., 1993, 39, 351. (Pubitemid 23274435)
5. Franks S.: "Genetic and environmental origins of obesity relevant to reproduction". Reprod. Biomed. Online, 2006, 12, 526.
6. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A.: "Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome". Diabetes, 1989, 38, 1165. (Pubitemid 19250404)
7. Homburg R., Orvieto R., Bar-Hava I., Ben-Rafael Z.: "Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome". Hum. Reprod., 1996, 11, 716. (Pubitemid 26142162)
8. Dale O., Tanbo T., Haug E., Abyholm T.: "The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome". Hum. Reprod., 1998, 13, 567. (Pubitemid 28171947)
9. Costello M.F., Chapman M., Conway U.: "A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome". Hum. Reprod., 2006, 21, 1387. (Pubitemid 44445013)
10. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril., 89, 505.
11. Legro R.S., Finegood D., Dunaif A.: "A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome". J. Clin. Endocrinol. Metab., 1998, 83, 2694-8. (Pubitemid 28493762)
12. Muoio D.M., Newgard C.B.: "Metabolism: A is for adipokine". Nature, 2005, 436, 337.
13. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M. et al.: "Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes". Nature, 2005, 436, 356. (Pubitemid 41065039)
14. Graham T.E., Yang Q., Bluher M., Hammarstedt A., Ciaraldi T.P., Henry R.R. et al.: "Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects". N. Engl. J. Med., 2006, 354, 2552.
15. Chan T.F., Tsai Y.C., Chiu P.R., Chen Y.L., Lee C.H., Tsai E.M.: "Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome". Fertil. Steril., 2010, 93, 869.
16. Hutchison S.K., Harrison C., Stepto N., Meyer C., Teede H.J.: "Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome". Diabetes Care, 2008, 31, 1427.
17. Möhlig M., Weickert M.O., Ghadamgahi E., Arafat A.M., Spranger J, Pfeiffer A.F., Schöfl C.: "Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome". Eur. J. Endocrinol., 2008, 158, 517.
18. Lee J.W., Im J.A., Lee D.C., Lee H.R., Shim J.Y.: "Retinol-binding protein in nonobese women with polycystic ovary syndrome". Clin. Endocrinol., 2008, 68, 786.
19. Hahn S., Backhaus M., Broecker-Preuss M., Tan S., Dietz T., Kimmig R. et al.: "Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism". Eur. J. Endocrinol., 2007, 157, 201.
20. Weiping L., Qingfeng C., Shikun M., Xiurong L., Hua Q., Xiaoshu B.: "Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome". Endocrine, 2006, 30, 283.
21. Tan B.K., Chen J., Lehnert H., Kennedy R., Randeva H.S.: "Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids". J. Clin. Endocrinol. Metab., 2007, 92, 2764.
22. Orvieto R.: "Can we eliminate severe ovarian hyperstimulation syndrome?". Hum. Reprod., 2005, 20, 320.
23. Barber T.M., Hazell M., Christodoulides C., Golding S.J., Alvey C, Burling K.: "Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition". J. Clin. Endocrinol. Metab., 2008, 93, 2859.
24. Orvieto R., Meltcer S., Nahum R., Rabinson J., Anteby E.Y., Ashkenazi J.: "The influence of body mass index on in vitro fertilization outcome". Int. J. Gynaecol. Obstet., 2009, 104, 53.